GUANGZHOU PHAR<00874> - Unusual volume movement

The Stock Exchange has received a message from Guangzhou Pharmaceutical
Company Limited which is reproduced as follows:-

"This statement is made at the request of The Stock Exchange of Hong Kong 
Limited.

The board of directors (the "Directors") have noted the recent increase of 
trading volume of the shares of Guangzhou Pharmaceutical Company Limited 
(the "Company") and wish to state that the Directors are not aware of any 
reasons for such increase.

The Directors confirm that there are no negotiations or agreements 
relating to intended acquisitions or realisations which are discloseable 
under Rule 13.23, neither is the board of directors (the "Board") aware of 
any matter discloseable under the general obligation imposed by Rule 
13.09, which is or may be of a price-sensitive nature.

The Directors collectively and individually accept responsibility for the 
accuracy of this announcement.

By order of the Board
Guangzhou Pharmaceutical Company Limited


He Shuhua
Company Secretary

Guangzhou, the People's Republic of China, 12 January 2006

As at the date of this announcement, the Board comprises Mr. Yang 
Rongming, Mr. Zhou Yuejin, Mr. Xie Bin and Mr. Feng Zansheng as 
executive Directors, and Mr. Wu Zhang, Mr. Wong Hin Wing and 
Mr. Zhang Heyong as independent non-executive Directors."